Canopy Growth Corp
TSX:WEED
Intrinsic Value
Canopy Growth Corp. engages in the production and sale of medical cannabis. [ Read More ]
The intrinsic value of one WEED stock under the Base Case scenario is 10.61 CAD. Compared to the current market price of 13.94 CAD, Canopy Growth Corp is Overvalued by 24%.
Valuation Backtest
Canopy Growth Corp
Run backtest to discover the historical profit from buying and selling WEED stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Canopy Growth Corp
Current Assets | 397.3m |
Cash & Short-Term Investments | 186.2m |
Receivables | 63.9m |
Other Current Assets | 147.2m |
Non-Current Assets | 962.5m |
Long-Term Investments | 392.3m |
PP&E | 340.5m |
Intangibles | 204.3m |
Other Non-Current Assets | 25.4m |
Current Liabilities | 221.3m |
Accounts Payable | 25.8m |
Accrued Liabilities | 17.1m |
Other Current Liabilities | 178.4m |
Non-Current Liabilities | 593.9m |
Long-Term Debt | 587.9m |
Other Non-Current Liabilities | 6m |
Earnings Waterfall
Canopy Growth Corp
Revenue
|
298.1m
CAD
|
Cost of Revenue
|
-336.8m
CAD
|
Gross Profit
|
-38.7m
CAD
|
Operating Expenses
|
-298.7m
CAD
|
Operating Income
|
-337.4m
CAD
|
Other Expenses
|
-939.1m
CAD
|
Net Income
|
-1.3B
CAD
|
Free Cash Flow Analysis
Canopy Growth Corp
WEED Profitability Score
Profitability Due Diligence
Canopy Growth Corp's profitability score is 8/100. The higher the profitability score, the more profitable the company is.
Score
Canopy Growth Corp's profitability score is 8/100. The higher the profitability score, the more profitable the company is.
WEED Solvency Score
Solvency Due Diligence
Canopy Growth Corp's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Score
Canopy Growth Corp's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WEED Price Targets Summary
Canopy Growth Corp
According to Wall Street analysts, the average 1-year price target for WEED is 6.69 CAD .
Shareholder Return
WEED Price
Canopy Growth Corp
Average Annual Return | -42.74% |
Standard Deviation of Annual Returns | 47.32% |
Max Drawdown | -99% |
Market Capitalization | 1.2B CAD |
Shares Outstanding | 82 931 963 |
Percentage of Shares Shorted | 3.83% |
WEED News
Last Important Events
Canopy Growth Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Canopy Growth Corp
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Canopy Growth Corp. engages in the production and sale of medical cannabis. The company is headquartered in Smiths Falls, Ontario and currently employs 3,259 full-time employees. The company went IPO on 2010-06-04. The firm operates through two segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment comprises the production, distribution and sale of consumer products, including Storz & Bickel vaporizers; This Works beauty, skincare, wellness and sleep products; BioSteel sports nutrition beverages, mixes, protein, gum and mints; and other revenue sources.
Contact
IPO
Employees
Officers
The intrinsic value of one WEED stock under the Base Case scenario is 10.61 CAD.
Compared to the current market price of 13.94 CAD, Canopy Growth Corp is Overvalued by 24%.